Comparing clinical and genomic features based on the tumor location in patients with resected pancreatic cancer
We could not find differences in prognosis and tumor biology depending on tumor location in pancreatic ductal adenocarcinoma. Discrepancies in prognosis may represent a combination of lead time, selection bias, and clinical differences, including the surgical burden between tumor sites.
Authors
- Wooil Kwon (ORCID: https://orcid.org/0000-0002-4827-7805)
- Daechan Park (ORCID: https://orcid.org/0000-0003-4991-5247)
- Won‐Gun Yun (ORCID: https://orcid.org/0000-0002-4023-4739)
- Young‐Jae Cho (ORCID: https://orcid.org/0000-0001-6943-4462)
- Mirang Lee (ORCID: https://orcid.org/0000-0002-3171-2540)
- Jin‐Young Jang (ORCID: https://orcid.org/0000-0003-3312-0503)
- Hye‐Sol Jung (ORCID: https://orcid.org/0000-0002-2041-4214)
- Joon Seong Park (ORCID: https://orcid.org/0000-0001-7999-0577)
- Daeun Kim (ORCID: https://orcid.org/0000-0003-3382-2812)
- Yoon Soo Chae (ORCID: https://orcid.org/0000-0003-2762-3286)
- Youngmin Han
Institutions
- Seoul National University (KR)
- Cancer Research Institute (US)
- National University College (PR)
- Ajou University (KR)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-08-26
- DOI
- https://doi.org/10.1186/s12885-024-12795-5
- Citations
- 3
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- National Research Foundation
- Korea Health Industry Development Institute
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea